US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.15

-0.0133-0.06%

Volume:494

Turnover:11.43K

Market Cap:4.63M

PE:- -

High:23.15

Open:23.12

Low:23.12

Close:23.16

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.63

T/O Rate:0.25%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics

Shandong Boan Biotechnology's Cancer Drug Candidate Gets IND Acceptance; Shares Down 5%

MT Newswires Live

Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling

Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA

MT Newswires Live

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection

India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence

India's Stock Market Emerges as a Global Safe Haven Amid AI-Driven Volatility

India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence

India Ratings assigns and affirms IND BBB+ / A2 ratings to Foods & Inns bank facilities

Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance

Benzinga_recent_news

Edding Genor Receives NMPA Approval for Phase Ib/II Clinical Trial of GB268

OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026

NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101

Gain Therapeutics receives FDA clearance of GT-02287 IND application

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026

India's Economy Poised to Approach 8% Growth, Says PM Modi's Top Aide

ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases

JSW Energy Subsidiary JSW Renew Energy Three Gets IND A/Stable Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IND/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.145,"timestamp":1788206400000,"preClose":23.1583,"halted":0,"volume":494,"delay":0,"changeRate":-0.0005743081314259241,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Pre-Mkt","change":-0.0133,"latestTime":"09-01 09:05:54 EDT","open":23.115,"high":23.145,"low":23.115,"amount":11430,"amplitude":0.001295,"askPrice":24,"askSize":19,"bidPrice":9.26,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":23.145,"sharesOutstanding":200001,"nav":23.107,"aum":4621406.79,"dividendRate":0.003409,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.115,"preClose":23.145,"latestTime":"16:10 EDT","volume":7,"amount":162.015,"timestamp":1788207004404,"change":-0.03,"changeRate":-0.001296,"amplitude":0},"volumeRatio":0.6283389809433055},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6283389809433055,"shares":200001,"dividePrice":0.0789,"high":23.145,"amplitude":0.001295,"preClose":23.1583,"low":23.115,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.145,"committee":0.826484,"eps":0,"divideRate":0.003409,"volume":494,"delay":0,"ttmEps":0,"open":23.115,"prevYearClose":24.78,"prevWeekClose":23.1583,"prevMonthClose":23.145,"prevQuarterClose":22.88,"fiveDayClose":23.065,"twentyDayClose":23.01,"sixtyDayClose":22.2234},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649996156","title":"Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996156","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996156?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512000,"startTime":"0","endTime":"0","summary":"-- Arbitration tribunal declared that PM647 is within Prime Medicine’s “Field”, confirming Prime Medicine’s right to develop and commercialize PM647 in AATD --  -- Prime Medicine owes no monetary dama","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324031/0/en/Prime-Medicine-Announces-Positive-Resolution-to-Arbitration-with-Beam-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","CTA","BK4139","BK4539","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649968198","title":"Shandong Boan Biotechnology's Cancer Drug Candidate Gets IND Acceptance; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649968198","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649968198?lang=en_us&edition=fundamental","pubTime":"2026-07-08 14:16","pubTimestamp":1783491408,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co (HKG:6955) said its investigational new drug application for BA1203 has been accepted by China's Center for Drug Evaluation of the National Medical Products Administrati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06955","IND","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649987048","title":"Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling","url":"https://stock-news.laohu8.com/highlight/detail?id=2649987048","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649987048?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:30","pubTimestamp":1783427400,"startTime":"0","endTime":"0","summary":"Company also advances U.S. regulatory pathway for ONP-002 with FDA Type B meeting request All three Australian Phase IIa trial sites — Mackay Base Hospital, Alfred Health, and Royal Adelaide Hospital ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/07/3323198/0/en/Oragenics-Achieves-Full-Activation-of-Australian-Phase-IIa-Trial-Network-All-Three-Sites-Now-Enrolling.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4139","IND","OGEN","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649118606","title":"Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2649118606","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649118606?lang=en_us&edition=fundamental","pubTime":"2026-07-07 12:17","pubTimestamp":1783397876,"startTime":"0","endTime":"0","summary":"Celltrion  submitted an investigational new drug  amendment for a global Phase 3 trial of CT-P51, the biosimilar of its cancer drug Keytruda, to the U.S. Food & Drug Administration, according to a Monday filing with the Korea Exchange.The randomized, double-blind, active-controlled clinical trial will enroll 220 previously untreated patients who have metastatic non-squamous non-small cell lung cancer to compare the efficacy and safety of CT-P51 against the reference drug over a two-year treatment period, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IND.AU","IND","BK7095","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649235026","title":"Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2649235026","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649235026?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:00","pubTimestamp":1783332000,"startTime":"0","endTime":"0","summary":"Key Points Immuron Engages Pullan Consulting to Advance IMM-529 Partnering StrategyImmuron is seeking a partner to support clinical development through regulatory approval and commercializationImmuron","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/06/3322259/37134/en/Immuron-Advances-IMM-529-Clostridioides-difficile-infection-Partnering-Strategy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","IMRN","BK4213","IND","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155756914","title":"ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1155756914","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155756914?lang=en_us&edition=fundamental","pubTime":"2026-07-06 08:10","pubTimestamp":1783296638,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced it recently submitted two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA).The applications are for a next-generation,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","BK1515","BK4590","BK1191","BK4160","GLP","IND","BK4144","BK4585","LABU","BK1161","GIPR","01477","JDOC","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183558958","title":"India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence","url":"https://stock-news.laohu8.com/highlight/detail?id=1183558958","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183558958?lang=en_us&edition=fundamental","pubTime":"2026-07-05 21:21","pubTimestamp":1783257672,"startTime":"0","endTime":"0","summary":"Global investors are reassessing the value of allocating funds to the Indian stock market. At a time when AI-driven trading continues to amplify volatility across global markets, India's market,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKEM","XXCH","BK4585","INQQ","VEU","FLIN","XSOE","INDL","DEXC","AVEM","FEMR","KEMX","HEEM","IMVP","ARTY","INDH","INCO","BKF","INDE","PIN","EEMA","SEEM","XC","GLIN","SCIN","EPI","MFEM","QEMM","DFAE","EEMV","IND","BK4523","NDIA","SPEM","BBEM","VTHR","XCEM","QLVE","AIPO","INDA","ASIA","EET","BK4588","NFTY","SMIN","QTOC","SCHE","BCHI","AGIX","EMXC","STXE","CHAT","RWEM","PEMX","BK4550","IOPP","INDY","EQLT","MEMX","MEM","XCNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161120576","title":"India's Stock Market Emerges as a Global Safe Haven Amid AI-Driven Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=1161120576","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161120576?lang=en_us&edition=fundamental","pubTime":"2026-07-05 19:51","pubTimestamp":1783252276,"startTime":"0","endTime":"0","summary":"India's stock market, with its low correlation to the artificial intelligence theme, is becoming a hedging tool for risk diversification within emerging market portfolios, transforming its perceived...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4523","ASIA","AGIX","BK4550","XC","FLIN","SPEM","XCNY","MEM","SEEM","DEXC","BBEM","ARTY","IMVP","KEMX","VEU","BK4585","DFAE","INCO","XXCH","NFTY","INDL","QEMM","EPI","INDY","INDE","SMIN","INQQ","MEMX","VTHR","SCIN","AIPO","EEMV","BK4588","GLIN","BKF","BCHI","NDIA","PEMX","CHAT","EQLT","EEMA","RWEM","EET","EMXC","HEEM","QLVE","IOPP","QTOC","AVEM","SCHE","BKEM","PIN","STXE","XSOE","INDA","IND","INDH","XCEM","MFEM","FEMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138230472","title":"India's Stock Market Emerges as a Defensive Haven Amid Global AI Turbulence","url":"https://stock-news.laohu8.com/highlight/detail?id=1138230472","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138230472?lang=en_us&edition=fundamental","pubTime":"2026-07-05 18:03","pubTimestamp":1783245823,"startTime":"0","endTime":"0","summary":"Global investors are reassessing the value of allocating to Indian equities. At a time when artificial intelligence trading continues to amplify volatility across global markets, the Indian market,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","MEM","PIN","PEMX","AIPO","BKF","DEXC","MEMX","EEMA","EPI","NFTY","SCHE","DFAE","EQLT","BK4585","SCIN","SEEM","VEU","BBEM","XC","INDH","BCHI","FEMR","AVEM","BK4550","INQQ","EEMV","FLIN","SPEM","VTHR","QTOC","AGIX","IOPP","QEMM","XCNY","BK4588","ASIA","RWEM","INDE","HEEM","QLVE","NDIA","MFEM","IND","INDL","BKEM","KEMX","INDA","XSOE","XCEM","STXE","INCO","GLIN","EMXC","CHAT","INDY","SMIN","XXCH","EET","IMVP","BK4523"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648695926","title":"India Ratings assigns and affirms IND BBB+ / A2 ratings to Foods & Inns bank facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2648695926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648695926?lang=en_us&edition=fundamental","pubTime":"2026-07-03 21:03","pubTimestamp":1783083808,"startTime":"0","endTime":"0","summary":"The latest update is out from Foods & Inns Ltd. ( ($IN:FOODSIN) ). Foods & Inns Ltd. has announced that India Ratings & Research has reviewed and a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-assigns-and-affirms-ind-bbb-a2-ratings-to-foods-inns-bank-facilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-assigns-and-affirms-ind-bbb-a2-ratings-to-foods-inns-bank-facilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBB","MNDmain","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648684703","title":"Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2648684703","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648684703?lang=en_us&edition=fundamental","pubTime":"2026-07-03 01:05","pubTimestamp":1783011900,"startTime":"0","endTime":"0","summary":"Abbisko and AstraZeneca will jointly develop a Phase 1/2 NSCLC therapy combining lumipodlin with Tagrisso after China's IND clearance.","market":"sh","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/07/02/Doctor-Hand-Point-Patient-Lung-X-ray-Fil.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=240,format=auto,quality=85/files/images/story/2026/07/02/Doctor-Hand-Point-Patient-Lung-X-ray-Fil.jpg"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/07/60253296/abbisko-astrazeneca-team-up-on-lung-cancer-drug-combo-after-china-trial-clearance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/07/60253296/abbisko-astrazeneca-team-up-on-lung-cancer-drug-combo-after-china-trial-clearance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4120","TISI","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100428930","title":"Edding Genor Receives NMPA Approval for Phase Ib/II Clinical Trial of GB268","url":"https://stock-news.laohu8.com/highlight/detail?id=1100428930","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100428930?lang=en_us&edition=fundamental","pubTime":"2026-07-02 22:35","pubTimestamp":1783002933,"startTime":"0","endTime":"0","summary":"Edding Genor (06998) has announced that its Investigational New Drug application for the Phase Ib/II clinical trial of GB268, a highly differentiated and innovative PD-1/CTLA-4/VEGF trispecific...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06998","IND","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648021135","title":"OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2648021135","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648021135?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:00","pubTimestamp":1782993600,"startTime":"0","endTime":"0","summary":"BOULDER, Colo., July  02, 2026  (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on developing novel precision medicines, today announce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/02/3321271/0/en/OnKure-Therapeutics-to-Host-Virtual-KOL-Event-to-Discuss-PI3K%CE%B1-Inhibitor-Medicines-Selectivity-Matters-Pan-Mutant-Allosteric-Inhibition-Delivers-on-July-15-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4181","HST","BK4134","BK4218","MDCO","TSRI","BK4585","BK4539","BK4588","BK4139","BK4007","LENZ","KOL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648546132","title":"NewcelX completes Type B Pre-IND meeting with FDA for NCEL-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2648546132","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648546132?lang=en_us&edition=fundamental","pubTime":"2026-07-01 21:35","pubTimestamp":1782912915,"startTime":"0","endTime":"0","summary":"NewcelX (NCEL) announced the completion of its Type B Pre-IND meeting with the U.S. Food and Drug Administration. The agency provided constructive ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newcelx-completes-type-b-pre-ind-meeting-with-fda-for-ncel-101-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newcelx-completes-type-b-pre-ind-meeting-with-fda-for-ncel-101-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NCEL","BK4139","BK4588","BK4585","IND","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302913","title":"Gain Therapeutics receives FDA clearance of GT-02287 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302913","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647302913?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:20","pubTimestamp":1782764450,"startTime":"0","endTime":"0","summary":"Gain Therapeutics (GANX) announced that the FDA has authorized the company’s investigational new drug, or IND, application for GT-02287. The FDA’s ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-receives-fda-clearance-of-gt-02287-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gain-therapeutics-receives-fda-clearance-of-gt-02287-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","BK4119","BK4588","GT","BK4139","LABU","BK4585","GANX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647472304","title":"DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2647472304","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647472304?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:00","pubTimestamp":1782763200,"startTime":"0","endTime":"0","summary":"Chtillon, France, June 29, 2026 DBV Technologies Provides BLA Submission Update for the VIASKIN Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3319270/0/en/DBV-Technologies-Provides-BLA-Submission-Update-for-the-VIASKIN-Peanut-Patch-in-Children-Aged-4-through-7-Years-Working-Collaboratively-with-FDA-to-Optimize-Review-Process-in-Prepa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","DBV","IND","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647937940","title":"Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647937940","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647937940?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:01","pubTimestamp":1782734460,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., June  29, 2026  (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3318916/36461/en/Voyager-s-Tau-Targeted-Gene-Therapy-VY1706-for-Alzheimer-s-Disease-to-Be-Featured-in-Developing-Topics-Poster-Presentation-at-AAIC-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","BK4132","AD","IND","BK4590","AAIC","GLP","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199283809","title":"India's Economy Poised to Approach 8% Growth, Says PM Modi's Top Aide","url":"https://stock-news.laohu8.com/highlight/detail?id=1199283809","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199283809?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:22","pubTimestamp":1782714152,"startTime":"0","endTime":"0","summary":"India's economy has the potential to once again approach an 8% annual growth rate if no major fresh global conflicts erupt, according to a top aide to Prime Minister Narendra Modi.Shaktikanta Das,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INQQ","NDIA","NFTY","SMIN","INDE","INCO","IND","INDL","IMVP","EPI","FLIN","PIN","BK4523","BK4585","BK4588","GLIN","INDA","EMXC","INDY","SCIN","MNDmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139407184","title":"ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases","url":"https://stock-news.laohu8.com/highlight/detail?id=1139407184","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139407184?lang=en_us&edition=fundamental","pubTime":"2026-06-29 14:22","pubTimestamp":1782714151,"startTime":"0","endTime":"0","summary":"Shares of ASCLETIS-B (HKEX: 01672) have risen more than 7%. At the time of writing, the stock is up 7.2%, trading at HK$10.42 with a turnover of HK$13.24 million. The company has announced that it...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIC","BK4588","IND","BK1515","BK1574","VXUS","01477","BK1191","BK4585","LABU","BK4104","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646908365","title":"JSW Energy Subsidiary JSW Renew Energy Three Gets IND A/Stable Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2646908365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646908365?lang=en_us&edition=fundamental","pubTime":"2026-06-26 22:22","pubTimestamp":1782483736,"startTime":"0","endTime":"0","summary":"JSW Energy Limited ( ($IN:JSWENERGY) ) just unveiled an announcement. India Ratings and Research has assigned an “IND A/Stable” credit rating to th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jsw-energy-subsidiary-jsw-renew-energy-three-gets-ind-a-stable-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jsw-energy-subsidiary-jsw-renew-energy-three-gets-ind-a-stable-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}